Repatha is the FIRST PCSK9 approved in Canada! Important news for all families with FH and uncontrolled LDL cholesterol at risk for cardiovascular disease.

September 17, 2015

HEALTH CANADA APPOVES AMGEN’S NEW CHOLESTEROL-LOWERING MEDICATION REPATHA (EVOLOCUMAB)

Repatha Reduced LDL-C by up to 75 Per Cent Compared with Placebo.

First in a New Class of Cholesterol-Lowering Drugs Offers Canadian Physicians and Patients a New Choice Cholesterol Management

Please read full news release below for more information on Repatha approval.

Please note: This information is for Canada Media Only

News and Events